Karaca, L. Et Al. 2023. Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?. European review for medical and pharmacological sciences , vol.27, no.22 , 11122-11130.

Karaca, L., Özdemir, Z. M., Kahraman, A., Çelik, H., & Kaya, S., (2023). Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?. European review for medical and pharmacological sciences , vol.27, no.22, 11122-11130.

Karaca, LEYLA Et Al. "Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?," European review for medical and pharmacological sciences , vol.27, no.22, 11122-11130, 2023

Karaca, LEYLA Et Al. "Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?." European review for medical and pharmacological sciences , vol.27, no.22, pp.11122-11130, 2023

Karaca, L. Et Al. (2023) . "Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?." European review for medical and pharmacological sciences , vol.27, no.22, pp.11122-11130.

@article{article, author={LEYLA KARACA Et Al. }, title={Assessment of quantitative zonal parameters of prostate gland in discrimination of normal, benign, and malignant conditions: are these the more reliable parameters in the diagnosis of prostate cancer?}, journal={European review for medical and pharmacological sciences}, year=2023, pages={11122-11130} }